The $50 Proteome.

High-throughput protein profiling to explore 1000 of the most informative proteins on one unified platform with absolute quantification - expertly curated to balance the critical must-haves, biological breadth, and real-world utility.

The only seamless end to end service to democratize proteomics for any study

380,000+

Samples profiled

61,500,000

Proteins profiled

+100

Institutions supported

1000

Proteins in catalog

True Multiplexing at Scale

Using DNA as a flexible, programmable linker to completely overcome cross-reactivity.

Accessible. Adaptable. Absolute.

Achieve multiplexing at-scale without the usual trade-offs.

Absolute Quantification

Broad profiling meets absolute quantification, delivering consistent precision with <10% intra-lot CV.

Accelerated Analysis

Intuitive analysis tools turn high-dimensional data into fast, actionable insights.

Flexible

Design the perfect panel with the flexibility to select proteins based on your goals, not predefined sets.

Rapid Turnaround Time

With turnaround times measured in days, not months, Nomic delivers proteomics data on your timeline—for thousands of samples.

Cost Effecient

Affordable protein profiling empowers researchers to scale studies without financial limits—enabling deeper discovery and broader impact.

High Fidelity

True multiplexing delivers high sensitivity and exquisite specificity—at scale.

Fast, High-Throughput Service Backed by Expert Support

The world’s fastest and most seamless protein profiling service—built on nELISA, powered by automation, and backed by experts—with turnaround times as fast as one week.

Nomic by the numbers

~0.1 pg/mL​

High-sensitivity​
nELISA assays​

<10% CV​

Intra-lotreproducibility

4-6 log​

Orders of Magnitude​
Dynamic Range​

99.99%​

Specificity​

High Throughput​

Tens of thousands of samples per week​

Cost Efficient​

Low cost per sample​

Proteomics
without compromise

Omni 1000

The most valuable human proteins cover 100% of the Reactome pathways and empower researchers with a catalog with proven utility across drug discovery and translational research.

Core

Designed for focused, high-impact research areas like inflammation and cardiometabolic disease to sharpen hypotheses, reinforce gut feelings, or confirm results.

Flex

When every sample is expensive, studies stay small—and so does their power to uncover real insights.

“Understanding and creating learning models to accelerate drug discovery is challenging. Nomic's nELISA platform allows us to understand, in an unbiased way; proteomics in relation to phenomics.”

Dale Wright
VP Biology, Recursion Pharmaceutical

Upcoming Events

June 24, 2025
June 25, 2025
Boston Convention & Exhibition Center, Boston, MA

The Festival of Genomics & Biodata

Meet Nomic Bio at FoG 2025
October 2, 2025
October 3, 2025
Sheraton San Diego Hotel & Marina, San Diego, CA

Discovery & Development US 2025

Nomic Team will soon be at San Diego
July 23, 2025
July 26, 2025
Baltimore Marriott Waterfront, Baltimore, MD

Basic Cardiovascular Sciences 2025

Why struggle to create a protein panel when we have one ready for you?
April 25, 2025
April 30, 2025
McCormick Place Convention Center, Chicago, Illinois

AACR Annual Meeting 2025

Join Nomic Team at AACR 2025, Chicago
November 9, 2025
November 13, 2025
Westin Harbour Castle, Toronto, ON, Canada

24th Human Proteome Organization World Congress 2025 (HUPO)

Join Nomic Team at HUPO 2025, Toronto
April 29, 2025
April 29, 2025
Spotlight Theater CMcCormick Place Convention Center, Chicago, Illinois

Lunch Event at AACR

Lunch with Nomic Bio team, and discuss the latest progress in proteomics space.
May 3, 2025
May 7, 2025
Hawaiʻi Convention Center, Honolulu, HI

Immunology 2025

Nomic is heading to Hawaii to shine in the proteomics world.

Latest Press

September 24, 2024

Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study

Project will quantify circulating protein markers in ~3000 patient blood samples from PICI’s RADIOHEAD study using Nomic’s nELISA™ high-throughput protein profiling platform to better understand how patients respond to treatment
December 8, 2021

Nomic Closes $17 Million Series A to Develop and Commercialize the World’s Highest Throughput Proteomic Platform

Nomic is closing of an oversubscribed US$17 million Series A funding round, bringing the company's total funding to date to over US$21 million.
June 28, 2023

Nomic Bio Appoints Byron Hewett to its Board of Directors

Hewett brings invaluable operational and strategic expertise to guide Nomic Bio through its crucial years of growth.
December 8, 2021

Nomic to Provide nELISA to JUMP Cell Painting Consortium to Measure Protein Secretome for Phenotypic Drug Discovery

Nomic’s nELISA will be used to profile 200 secreted proteins for ten thousand samples to provide consortium partners complementary information about the secretome
September 17, 2024

Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling

The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.
January 3, 2025

Bridging the Gaps in Proteomics

Enabling well-powered studies, absolute quantification, and unlimited content flexibility

Get the latest in proteomics, straight to your inbox

Be the first to hear about new targets, product updates, data highlights, and upcoming events.